Glycopyrrolate + Formoterol Suppliers & Bulk Manufacturers

Available Forms: Pressurized metered-dose inhaler (pMDI)

Available Strengths: Glycopyrrolate 9 mcg + Formoterol fumarate 4.8 mcg

Reference Brands: Bevespi Aerosphere(US)

Category: Respiratory Disorder

Glycopyrrolate + Formoterol is available in Pressurized metered-dose inhaler (pMDI) and strengths such as Glycopyrrolate 9 mcg + Formoterol fumarate 4.8 mcg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Glycopyrrolate + Formoterol is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Glycopyrrolate + Formoterol can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description:

Glycopyrrolate + Formoterol is a long-acting bronchodilator combination used for the maintenance treatment of chronic obstructive pulmonary disease (COPD). Glycopyrrolate, a LAMA, and Formoterol, a LABA, work together to relax airway muscles, improve airflow, and reduce symptoms like breathlessness. Marketed as Bevespi Aerosphere in the United States, this combination is delivered via a pressurized metered-dose inhaler (pMDI) and taken twice daily. It is not intended for acute symptom relief but provides long-term control of COPD symptoms. Bevespi Aerosphere helps enhance lung function, reduce exacerbations, and improve the overall quality of life for patients with moderate to severe COPD.